This edition of Antibody Industrial Symposium has already taken place.
Search future editions →Events › Healthcare & MedTech
Healthcare & MedTech
14th edition
The 14th Antibody Industrial Symposium 2026 (AIS2026) in Montpellier, France, is a premier international conference focused on therapeutic antibody R&D, bispecifics, ADCs, and cell/gene therapies. It brings together industrial and academic experts to explore advances and foster collaboration.
Attendees: Scientists, industrials, clinicians, and policy makers in therapeutic antibodies/recombinant proteins.
Exhibitor mix: Therapeutic antibodies, Recombinant proteins, Bioprocessing, ADC, Drug discovery services
Planning for next year?
Dozens of solution providers here. You probably care about 20–30. Tell us your ICP, we'll find them.
Request intelligence →Delivery within 24 hours · $1,250
Venue
Le Corum - Palais des Congrès - Opéra BerliozConvention centre · 6,000 m² · ~2,000 people
A central Montpellier venue hosting congresses, exhibitions, and opera. It features 6,000 sqm of exhibition space, 3 auditoriums (2,000, 745, and 318 seats), and 25 meeting rooms, managed by Montpellier Events.
📍 Esplanade Charles de Gaulle, 34000 Montpellier, France
Operated by Montpellier Events
Organizer
LabEx MAbImprove and MabDesignNonprofit · Lyon, France · Founded 2014
French industrial association for the biotherapy sector, supporting the development of therapeutic antibodies and vaccines.
Exhibitor list
56 companies are exhibiting at Antibody Industrial Symposium. A sample of 12 is shown below — unlock the full list to see all 56.
Also exhibits at Scottish Skipper Expo, International Pharmaceutical Expo, BIO-Europe
Also exhibits at Discovery on Target, European Congress on Biotechnology, PEGS Boston
Also exhibits at INTERPHEX, International Pharmaceutical Expo, ASMS Annual Meeting: Focus on Skin Cancer
Also exhibits at ISCT Annual Meeting
Also exhibits at 14th PharmaLab Congress
44 more exhibitors at Antibody Industrial Symposium.
Unlock the complete exhibitor list — every company, with optional ICP filtering and verified buying-committee contacts per matched account.
Why people attend
Key industry players attend to discover new technologies in antibody development, connect with CDMOs, and engage in high-level scientific networking with experts.
Exhibitor categories
Speakers
135 speakers at Antibody Industrial Symposium
Independent biotech Consultant · Lust for Life Science
"Mining Antibody Biology for Novel Functionalities and Therapeutic Antibody Development"
Also speaking at Antibody Industrial Symposium 2027
SVP Biology · EVOTEC
"Integrated Drug Discovery Continuum at Evotec"
Also speaking at Antibody Industrial Symposium 2027
Senior Research Scientist - In Vitro Biology · EVOTEC
"30 Years of Phage Display Supporting the Discovery of Meaningful Therapeutic Antibodies"
Also speaking at Antibody Industrial Symposium 2027
Research Scientist - Biophysics · EVOTEC
"Biophysical Interaction Mapping for Antibodies"
Also speaking at Antibody Industrial Symposium 2027
Group Leader - Bioservices and Welfare · EVOTEC
"De-Risking and Predicting the Behavior of Therapeutic Antibodies and Their Derivatives"
Also speaking at Antibody Industrial Symposium 2027
VP - Head of Molecular Architects · EVOTEC
"Antibody-Drug Conjugates (ADCs) Drug Discovery"
Also speaking at Antibody Industrial Symposium 2027
VP Immuno-Oncology - In Vitro Biology · EVOTEC
"Pharmacological Support for Antibody Discovery – Immune Synapse"
Also speaking at Antibody Industrial Symposium 2027
Senior Research Scientist - Immuno-Oncology In Vivo · EVOTEC
"Humanized Mouse Models Supporting Antibody Profiling"
Also speaking at Antibody Industrial Symposium 2027
Principal Scientist - Protein Sciences · EVOTEC
"Production, Early Developability Assessment and Affinity Maturation in Antibody Drug Discovery"
Also speaking at Antibody Industrial Symposium 2027
Associate VP - Business Development · JUST - EVOTEC BIOLOGICS
"Just’s Molecular Design and Manufacturing Platform"
Also speaking at Digital Construction Week, Antibody Industrial Symposium 2027
PU-PH - Head of the Clinical Hematology Department · Montpellier University Hospital
"How Antibody-Based Therapies Were Game Changers in the Treatment of Patients With Hematologic Cancers"
Also speaking at Antibody Industrial Symposium 2027
Head of the department of nuclear medicine · UZ Brussel, Vrije Universiteit Brussel
"Radiolabelled antibody fragments for use in treating cancer"
Also speaking at Antibody Industrial Symposium 2027
Professor · Vrije Universiteit Brussel
"Radiolabelled sdAb for radioligand therapy of cancer"
Also speaking at Antibody Industrial Symposium 2027
Group Leader · Institut de Recherche en Cancérologie Montpellier (IRCM)
"Antibody–radionuclide conjugates"
Also speaking at Antibody Industrial Symposium 2027
Field Application Scientist · Nuclera
"Cell-Free Triage of AI Antibodies Predicts CHO Kinetics"
Also speaking at Antibody Industrial Symposium 2027
Senior Director of Biologics Discovery Microfuildics Team · SANOFI
"Organoid cultures / tumoroids for Drug Screening"
After completing his Ph.D. studies in 2009 in microfluidic chip field, Guillaume Mottet continued as postdoctoral fellow at Institut Curie in the team of Jean Louis Viovy and developed thermoplastic chips for diagnostics. In 2013, he went on to apply droplet microfluidics for the study of molecular evolution in the lab of Andrew Griffiths at ESPCI, and in 2015 he joined the team of Pierre Bruhns at Institut Pasteur, where he implemented a single-cell droplet microfluidic platform for high throughput B cell analysis. Now at Sanofi, he is taking on a leading role in the microfluidics team with the goal to develop new technology for drug discovery.
Also speaking at Antibody Industrial Symposium 2027
+ 119 more speakers at this event.
More Healthcare & MedTech events
Frequently asked questions